Anna Nowak
Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; New York Univeristy, Grossmann School of Medicine · NYU Langone Health · Faculty of Health and Medical Sciences University of Western Australia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anna Nowak as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07795957 · GOAt Milk Formula-based Ladder Versus Cow's Milk LadderMedical University of Warsaw · not yet recruiting · Food Allergy, Cow's Milk Protein Allergy, Cow's Milk Allergy · principal investigator
- N/ANCT07040111 · Efficacy and Safety of Egg Ladders in Children With IgE-Mediated Hen's Egg Protein AllergyMedical University of Warsaw · not yet recruiting · Food Allergy, Egg Allergy, Hen Egg Allergy · principal investigator
- N/ANCT06683521 · Immunologic Basis of Food Protein-Induced Enterocolitis SyndromeNYU Langone Health · recruiting · Food Protein-Induced Enterocolitis Syndrome · principal investigator
- N/ANCT06664918 · Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein AllergyMedical University of Warsaw · recruiting · Cow Milk Allergy, Food Allergy · principal investigator
- Ph3NCT04334759 · DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaPrECOG, LLC. · completed · Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma · study chair
- N/ANCT03236207 · Hypoallergenicity Evaluation of a New Extensively Hydrolyzed FormulaSociété des Produits Nestlé (SPN) · completed · Cow Milk Allergy · principal investigator
- N/ANCT02450643 · Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed FormulaSociété des Produits Nestlé (SPN) · completed · Cow's Milk Allergy · principal investigator
- N/ANCT01569776 · Elemental Formula HypoallergenicitySociété des Produits Nestlé (SPN) · completed · Food Hypersensitivity · principal investigator
- N/ANCT01278446 · Extensively Hydrolyzed Formula: HypoallergenicitySociété des Produits Nestlé (SPN) · completed · Food Hypersensitivity · principal investigator
- Ph2NCT00778258 · Study of Milk Allergy and Tolerance in ChildrenNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Food Hypersensitivity, Milk Hypersensitivity · study chair
- Ph3NCT00626990 · Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)European Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Brain and Central Nervous System Tumors · study chair
- Early Ph1NCT00578656 · An Interventional Study of Milk AllergyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Food Hypersensitivity, Milk Hypersensitivity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Immune Basis of FPIESU01AI170836 · NIAID · NORTHWESTERN UNIVERSITY · fiscal years 2022 to 2026 · $1,020,297 awarded in 2026Grant number is on one of their registry trials
- CLINICAL COREU19AI136053 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2018 to 2022 · $536,117 awarded in 2022Same name and institution; not confirmed by an ID
- Immunological Basis of Egg AllergyK23AI059318 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2005 to 2009 · $128,655 awarded in 2009Same name and institution; not confirmed by an ID
- IMMUNOLOGICAL BASIS OF EGG ALLERGYM01RR000071 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · fiscal years 2005 to 2009 · $7,096 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:27 UTC. The ranking covers the 200 most relevant of 135 PubMed records, and a shared surname and initials can bring in a namesake. All 135 on PubMed
- 1,015 citationsRCR 56.5
- 339 citationsRCR 10.2
- 282 citationsRCR 16.7
- 248 citationsRCR 15.0
- A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.Br J Cancer · 2002150 citationsRCR 4.0
- Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.Lancet Oncol · 2020143 citationsRCR 5.8
- The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls.Int J Mol Sci · 2019140 citationsRCR 7.7
- Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.Neuro Oncol · 2015127 citationsRCR 4.2
- Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.Lancet Respir Med · 2019122 citationsRCR 4.8
- 119 citationsRCR 2.8